The management of inflammation in rheumatic diseases.
Drugs used to control inflammation in the rheumatic diseases are extremely diverse. Despite this, the pattern of clinical response and similarities in side-effects allow them to be subdivided into groups. These patterns also provide clues about the mode of action of the drugs. Conversely, studies of the mechanisms of action of drugs  used to treat rheumatoid arthritis are beginning to throw light on the pathological process.
D000305:Adrenal Cortex Hormones / Q000502:physiology; D000893:Anti-Inflammatory Agents / Q000145:classification; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D012898:Autacoids / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D011448:Prostaglandin Antagonists
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D012898:Autacoids; D007166:Immunosuppressive Agents; D011448:Prostaglandin Antagonists; D007213:Indomethacin